16370 Federal Register / Vol. 72, No. 64 / Wednesday, April 4, 2007 / Notices 

pharmacies, doctors’ offices, and 

community centers. 

In the Fall of 2005, the Spanish 

language campaign was pilot tested by 

5 state health departments that receive 

funding from CDC for their arthritis 

programs. CDC will eventually 

disseminate these materials to all 36 

CDC-funded states. The 5 preliminary 

pilot tests focused on reach and 

exposure; a more thorough evaluation is 

necessary to assess impact of the 

campaign. This information will be used 

to guide the public health practice of the 

36 state arthritis programs and their 

partners. 

CDC will conduct an evaluation of the 

impact of the Spanish language health 

communications campaign on the 

exercise/physical activity-related 

attitudes, beliefs, and behaviors among 

the target audience of Spanish-speaking 

people with arthritis. There are no costs 

to the respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Screening Survey ............................................................................................ 12,000 1 2/60 400 

Telephone Survey ............................................................................................ 2,500 1 15/60 625 

Total .......................................................................................................... ........................ ........................ ........................ 1,025 

Dated: March 28, 2007. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–6276 Filed 4–3–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Technical 

Support for Birth Defects and 

Developmental Disabilities Prevention 

Education Efforts, Contract Solicitation 

Number (CSN) 2006–N–08835 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned SEP: 

Time and Date: 12 p.m.–3 p.m., April 

30, 2007 (Closed). 

Place: Teleconference, Centers for 

Disease Control and Prevention, 1600 

Clifton Road, NE., Atlanta, GA 30333. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92–

463. 

Matters to be Discussed: The meeting 

will include the review, discussion, and 

evaluation of applications received in 

response to CSN 2006–N–08835, 

‘‘Technical Support for Birth Defects 

and Developmental Disabilities 

Prevention Education Efforts.’’

For Further Information Contact: 

Christine Morrison, Ph.D., Scientific 

Review Administrator, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE., Mailstop D72, Atlanta, 

GA 30333, Telephone 404.639.3098. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: March 28, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–6270 Filed 4–3–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Preparation for International 

Conference on Harmonisation 

Meetings in Brussels, Belgium; Public 

Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of meeting. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing a 

public meeting entitled ‘‘Preparation for 

ICH Meetings in Brussels, Belgium’’ to 

provide information and receive 

comments on the International 

Conference on Harmonisation (ICH) as 

well as the upcoming meetings in 

Brussels, Belgium. The topics to be 

discussed are the topics for discussion 

at the forthcoming ICH steering 

committee meeting. The purpose of the 

meeting is to solicit public input prior 

to the next steering committee and 

expert working groups meetings in 

Brussels, Belgium May 5–10, 2007, at 

which discussion of the topics 

underway and the future of ICH will 

continue. 

Date and Time: The meeting will be 

held on Friday April 6, 2007, from 3:30 

p.m. to 5 p.m. 

Location: The meeting will be held at 

5600 Fishers Lane, third floor, 

Conference Room G, Rockville, MD 

20857. For security reasons, all 

attendees are asked to arrive no later 

than 3:20 p.m., as you will be escorted 

from the front entrance of 5600 Fishers 

Lane to Conference Room G. 

Contact Person: Michelle Limoli, 

Office of the Commissioner (HFG–1), 

Food and Drug Administration, 5600 

Fishers Lane, Rockville, MD 20857, 

301–827–0908, e-mail: 

michelle.limoli@fda.hhs.gov, FAX: 301–

827–0003. 

Registration and Requests for Oral 

Presentations: Send registration 

information (including name, title, firm 

name, address, telephone, and fax 

number), written material, and requests 

to make oral presentations, to the 

contact person by April 5, 2007. 

If you need special accommodations 

due to a disability, please contact 

Michelle Limoli as soon as possible. 

SUPPLEMENTARY INFORMATION: The ICH 

was established in 1990 as a joint 

regulatory/industry project to improve, 

through harmonization, the efficiency of 

the process for developing and 

registering new medicinal products in 

Europe, Japan, and the United States 

without compromising the regulatory 

obligations of safety and effectiveness. 

In recent years, many important 

initiatives have been undertaken by 

regulatory authorities and industry 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 72, No. 64 / Wednesday, April 4, 2007 / Notices 16371 

associations to promote international 

harmonization of regulatory 

requirements. FDA has participated in 

many meetings designed to enhance 

harmonization and is committed to 

seeking scientifically-based harmonized 

technical procedures for pharmaceutical 

development. One of the goals of 

harmonization is to identify and then 

reduce differences in technical 

requirements for medical product 

development among regulatory 

agencies. ICH was organized to provide 

an opportunity for harmonization 

initiatives to be developed with input 

from both regulatory and industry 

representatives. ICH is concerned with 

harmonization among three regions: The 

European Union, Japan, and the United 

States. The six ICH sponsors are the 

European Commission; the European 

Federation of Pharmaceutical Industries 

Associations; the Japanese Ministry of 

Health, Labor and Welfare; the Japanese 

Pharmaceutical Manufacturers 

Association; the Centers for Drug 

Evaluation and Research and Biologics 

Evaluation and Research, FDA; and the 

Pharmaceutical Research and 

Manufacturers of America. The ICH 

Secretariat, which coordinates the 

preparation of documentation, is 

provided by the International 

Federation of Pharmaceutical 

Manufacturers Associations. The ICH 

steering committee includes 

representatives from each of the ICH 

sponsors and Health Canada, the 

European Free Trade Area, and the 

World Health Organization. The ICH 

process has achieved significant 

harmonization of the technical 

requirements for the approval of 

pharmaceuticals for human use in the 

three ICH regions. 

The current ICH process and structure 

can be found at the following Web site: 

http://www.ich.org. 

Interested persons may present data, 

information, or views orally or in 

writing, on issues pending at the public 

meeting. Oral presentations from the 

public will be scheduled between 

approximately 4:30 p.m. and 5 p.m. 

Time allotted for oral presentations may 

be limited to 10 minutes. Those desiring 

to make oral presentations should notify 

the contact person by April 5, 2007, and 

submit a brief statement of the general 

nature of the evidence or arguments 

they which to present, the names and 

addresses, phone number, fax, and email of proposed participants, and an 

indication of the approximate time 

requested to make their presentation. 

The agenda for the public meeting 

will be made available via the Internet 

at http://www.fda.gov/cder/meeting/ 

ICH_20060508.htm. 

Transcripts: Transcripts of the 

meeting may be requested in writing 

from the Freedom of Information Office 

(HFI–35), Food and Drug 

Administration, 5600 Fishers Lane, rm. 

6–30, Rockville, MD 20857, 

approximately 15 working days after the 

meeting at a cost of 10 cents per page. 

Dated: March 28, 2007. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. 07–1633 Filed 3–29–07; 3:56 pm] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

List of Recipients of Indian Health 

Scholarships Under the Indian Health 

Scholarship Program 

The regulations governing Indian 

Health Care Improvement Act Programs 

(Pub. L. 94–437) provide at 42 CFR 

136.334 that the Indian Health Service 

shall publish annually in the Federal 

Register a list of recipients of Indian 

Health Scholarships, including the 

name of each recipient, school and 

Tribal affiliation, if applicable. These 

scholarships were awarded under the 

authority of Sections 103 and 104 of the 

Indian Health Care Improvement Act, 25 

U.S.C. 1613–1613a, as amended by the 

Indian Health Care Amendments of 

1988, Pub. L. 100–713. 

The following is a list of Indian 

Health Scholarship Recipients funded 

under Sections 103 and 104 for Fiscal 

Year 2006: 

Adams, Staci Brook, Northern 

Oklahoma College, Ponca Tribe of 

Indians of Oklahoma. 

Ahenakew, Carol Marie, Walla Walla 

College, Blackfeet Tribe of the 

Blackfeet Indian Reservation of 

Montana. 

Albers, Travis Alan, University of Mary, 

Turtle Mountain Band of Chippewa 

Indians of North Dakota. 

Allen, Bryan Zachary, Southwestern 

Oklahoma State University, Choctaw 

Nation of Oklahoma. 

Arredondo, Michael Howard, University 

of Minnesota/Duluth, Eastern 

Shawnee Tribe of Oklahoma. 

Augare-Deal, Rael, University of Kansas, 

Blackfeet Tribe of the Blackfeet Indian 

Reservation of Montana. 

Azure, Donna Rae, Turtle Mountain 

Community College, Turtle Mountain 

Band of Chippewa Indians of North 

Dakota. 

Azure, Krysten Ross, University of 

North Dakota, Sisseton-Wahpeton 

Sioux Tribe of the Lake Traverse 

Reservation, South Dakota. 

Babbitt, Jaime Lynn, Indiana University, 

Navajo Nation, Arizona, New 

Mexico& Utah. 

Baker, Allison Marie, University of 

North Dakota, Three Affiliated Tribes 

of the Fort Berthold Reservation, 

North Dakota. 

Baker, Laiel Inez, University of North 

Dakota, Three Affiliated Tribes of the 

Fort Berthold Reservation, North 

Dakota. 

Baker, Valerie, University of New 

Mexico, Navajo Nation, Arizona, New 

Mexico & Utah. 

Bales-Poirot, Deidre Leann, University 

of Missouri/Columbia, Eastern 

Shawnee Tribe of Oklahoma. 

Banteah, Melinda Erika, University of 

New Mexico/Albuquerque, Zuni Tribe 

of the Zuni Reservation, New Mexico. 

Barnett, Stephanie Deann, University of 

Pittsburgh, Cherokee Nation, 

Oklahoma. 

Barrett, Courtney Paige, University of 

Oklahoma, Seminole Nation of 

Oklahoma. 

Bayer, Amelia Dianne, University of 

New Mexico, Choctaw Nation of 

Oklahoma. 

Beals, Bryan James, University of North 

Dakota, Muscogee (Creek) Nation, 

Oklahoma. 

Beardslee, Amber Rochelle, The 

University of Puget Sound, Central 

Council of Tlingit & Haida Indian 

Tribes. 

Beaver, Aaron Don, University of 

Oklahoma, Choctaw Nation of 

Oklahoma. 

Beaver, Allen Don, University of 

Oklahoma, Choctaw Nation of 

Oklahoma. 

Bebeau, Shari Kaye, University of 

Minnesota, Minnesota Chippewa 

Tribe, Minnesota. 

Becenti, Elton, New Mexico State 

University, Navajo Nation, Arizona, 

New Mexico & Utah. 

Becker, Tischa Lee, University of New 

Mexico, Cherokee Nation, Oklahoma. 

Begay, Melanie, University of New 

Mexico, Navajo Nation, Arizona, New 

Mexico & Utah. 

Begay, Monica Calley, University of 

New Mexico/Albuquerque, Navajo 

Nation, Arizona, New Mexico & Utah. 

Begay, Velda Ann, Arizona State 

University, Navajo Nation, Arizona, 

New Mexico & Utah. 

Begaye, Adrienne Marie, University of 

Arizona, Navajo Nation, Arizona, New 

Mexico & Utah. 

Begaye, Amelia June, University of New 

Mexico, Navajo Nation, Arizona, New 

Mexico & Utah. 

Begaye, Julianna, University of New 

Mexico, Navajo Nation, Arizona, New 

Mexico & Utah. 


jlentini on PROD1PC65 with NOTICES